PROFILAKSIS PRA-PAJANAN (PPrP) HIV/AIDS PADA LELAKI SEKS LELAKI

Authors

  • Teddy Tjahyanto Universitas Tarumanagara
  • Natasha Cita Paradhita Kusuma Universitas Tarumanagara
  • Agnes Marcella Universitas Tarumanagara
  • Gladys Ariella Universitas Tarumanagara
  • Alicia Sarijuwita Universitas Tarumanagara

DOI:

https://doi.org/10.31004/prepotif.v6i1.2816

Keywords:

Pre-exposure prophylaxis (PrEp), Human Immunodeficiency Virus (HIV), Men that have Sex with Men (MSM)

Abstract

Introduction: HIV is an infection that attacks the immune system which is characterized by a decrease in CD4+ cells with MSM as the 2nd largest contributor globally. PPrP serves as an additional option in the prevention of HIV-negative MSM from becoming infected with HIV. Objective: This study was conducted to review more deeply the role of pre-exposure prophylaxis in reducing the risk of contracting HIV in male sex groups with HIV negative men and to review the effectiveness and implementation of HIV/AIDS pre-exposure prophylaxis in male sex men so that it is expected to be a consideration in efforts to combat HIV/AIDS. Methods: Literature search was conducted from journal articles published online in the period 2012-2021. The databases used are ScienceDirect, Pubmed, Google Scholar, and Cochrane. Results: The study showed that the factors that significantly affected the high prevalence of HIV cases among MSM were anal sex and based on the findings the use of PrEP showed a significant effectiveness for the MSM group with pre-exposure prophylaxis as a preventive measure in dealing with HIV positive cases. Conclusion: PrEP has been shown to significantly reduce the risk of contracting HIV in HIV-negative MSM groups and has the potential to be an additional prevention option so that it can be applied in efforts to prevent HIV infection and reduce the spread of HIV in MSM.

References

amfAR. (2019). amfAR :: AIDS in Asia :: The Foundation for AIDS Research :: HIV / AIDS Research. AmfAR. https://www.amfar.org/hiv-in-asia/

AS, F. (2008). 25 years of HIV. Nature, 453(7193), 289–290. https://doi.org/10.1038/453289A

Baggaley, R. F., White, R. G., & Boily, M.-C. (2010). HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. International Journal of Epidemiology, 39(4), 1048–1063. https://doi.org/10.1093/IJE/DYQ057

Bavinton, B. R., & Grulich, A. E. (2021). HIV pre-exposure prophylaxis: scaling up for impact now and in the future. The Lancet Public Health, 6(7), e528–e533. https://doi.org/10.1016/S2468-2667(21)00112-2

CDC. (2011). CDC Interim Guidance on HIV PrEP for MSM | Graphic | Newsroom | NCHHSTP | CDC. CDC.GOV. https://www.cdc.gov/nchhstp/newsroom/2011/prepmsmguidancegraphic.html

CDC. (2016). HIV/AIDS Among Gay and Bisexual Men. https://www.cdc.gov/msmhealth/HIV.htm

Cempaka, R., Wardhani, B., Sawitri, A. A. S., Januraga, P. P., & Bavinton, B. (2020). PrEP Use Awareness and Interest Cascade among MSM and Transgender Women Living in Bali, Indonesia. Tropical Medicine and Infectious Disease 2020, Vol. 5, Page 158, 5(4), 158. https://doi.org/10.3390/TROPICALMED5040158

Chow, E. P. F., Chen, X., Zhao, J., Zhuang, X., Jing, J., & Zhang, L. (2015). Factors associated with self-reported unprotected anal intercourse among men who have sex with men in Changsha city of Hunan province, China. Http://Dx.Doi.Org/10.1080/09540121.2015.1058892, 27(10), 1332–1342. https://doi.org/10.1080/09540121.2015.1058892

Coyer, L., Elshout, M. A. M. van den, Achterbergh, R. C. A., Matser, A., Loeff, M. F. S. van der, Davidovich, U., Vries, H. J. C. de, Prins, M., Hoornenborg, E., & Boyd, A. (2020). Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men. EClinicalMedicine, 29, 100650. https://doi.org/10.1016/J.ECLINM.2020.100650

Dubov, A., Phillip Galbo, J., Altice, F. L., & Fraenkel, L. (2018). Stigma and Shame Experiences by MSM Who Take PrEP for HIV Prevention: A Qualitative Study: Https://Doi.Org/10.1177/1557988318797437, 12(6), 1843–1854. https://doi.org/10.1177/1557988318797437

European Centre for Disease Prevention and Control. (2021). HIV Pre-Exposure Prophylaxis in the EU/EEA and the UK: implementation, standards and monitoring. Operational guidance. https://www.ecdc.europa.eu/sites/default/files/documents/HIV-Pre-Exposure-Prophylaxis-in-the-EU-EEA-UK.pdf

Fouchier, R. A. M., Brouwer, M., Kootstra, N. A., Huisman, H. G., & Schuitemaker, H. (1994). HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle. Journal of Clinical Investigation, 94(5), 1806–1814. https://doi.org/10.1172/JCI117529

Ginsberg, G. M., & Chemtob, D. (2020). Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel. BMC Public Health 2020 20:1, 20(1), 1–14. https://doi.org/10.1186/S12889-020-8334-4

Griffin, J. A., Eldridge-Smith, E. D., Yohannan, J., & Stepleman, L. M. (2020). Pre-exposure Prophylaxis Knowledge and Use Among Men Who Have Sex With Men in a Small Metropolitan Region of the Southeastern United States. The Journal of the Association of Nurses in AIDS Care : JANAC, 31(1), 80–91. https://doi.org/10.1097/JNC.0000000000000115

Grulich, A. E., Guy, R., Amin, J., Jin, F., Selvey, C., Holden, J., Schmidt, H.-M. A., Zablotska, I., Price, K., Whittaker, B., Chant, K., Cooper, C., McGill, S., Telfer, B., Yeung, B., Levitt, G., Ogilvie, E. E., Dharan, N. J., Hammoud, M. A., … Parkhill, N. (2018). Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. The Lancet HIV, 5(11), e629–e637. https://doi.org/10.1016/S2352-3018(18)30215-7

Heendeniya, A., & Bogoch, I. I. (2019). Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention. Infectious Disease Clinics of North America, 33(3), 629–646. https://doi.org/10.1016/J.IDC.2019.04.002

Hillis, A., Germain, J., Hope, V., McVeigh, J., & Van Hout, M. C. (2020). Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming. AIDS and Behavior 2020 24:11, 24(11), 3056–3070. https://doi.org/10.1007/S10461-020-02855-9

Infodatin Kemenkes RI. (2014). Kementerian Kesehatan Republik Indonesia. Pusat Data dan Informasi (Profil Kesehatan Indonesia) (pp. 1–6). https://pusdatin.kemkes.go.id/article/view/20111200002/infodatin-hiv.html

Kemenkes. (2020). Laporan perkembangan HIV AIDS dan PIMS triwulan III tahun 2020. SIHA Kementerian Kesehatan RI. https://siha.kemkes.go.id/portal/files_upload/Laporan_Perkembangan_HIV_AIDS_dan_PIMS_Triwulan_III_Tahun_2020.pdf

Kemenkes RI. (2020). Arah dan Kebijakan Program Pencegahan dan Pengendalian Penyakit (P2P) Tahun 2020-2024. Kementerian Kesehatan RI. http://p2p.kemkes.go.id/arah-dan-kebijakan-program-pencegahan-dan-pengendalian-penyakit-p2p-tahun-2020-2024/

Kementerian Kesehatan Republik Indonesia. (2020). Monitoring dan Evaluasi Nasional Program Pengendalian HIV AIDS dan IMS Tahun 2020 dan Dukungan Global Fund AIDS Tahun 2021 – P2P Kemenkes RI. Direktorat Jenderal Pencegahan Dan Pengendalian Penyakit. http://p2p.kemkes.go.id/monitoring-dan-evaluasi-nasional-program-pengendalian-hiv-aids-dan-ims-tahun-2020-dan-dukungan-global-fund-aids-tahun-2021/

Li, R., Wang, H., Pan, X., Ma, Q., Chen, L., Zhou, X., Jiang, T., He, L., Chen, J., Zhang, X., Luo, Y., Xi, S., Lv, X., & Xia, S. (2017). Prevalence of condomless anal intercourse and recent HIV testing and their associated factors among men who have sex with men in Hangzhou, China: A respondent-driven sampling survey. PLOS ONE, 12(3), e0167730. https://doi.org/10.1371/JOURNAL.PONE.0167730

M, P., & J, C. (2006). Sexual behavior and perceived risk of HIV/AIDS among young migrant factory workers in Nepal. The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine, 38(3), 237–246. https://doi.org/10.1016/J.JADOHEALTH.2004.10.001

Mauck, D. E., Fennie, K. P., Ibañez, G. E., Fenkl, E. A., Sheehan, D. M., Maddox, L. M., Spencer, E. C., & Trepka, M. J. (2020). Estimating the size of HIV-negative MSM population that would benefit from pre-exposure prophylaxis in Florida. Annals of Epidemiology, 44, 52–56. https://doi.org/10.1016/J.ANNEPIDEM.2020.02.003

Mayer, K. H., Safren, S. A., Elsesser, S. A., Psaros, C., Tinsley, J. P., Marzinke, M., Clarke, W., Hendrix, C., Wade Taylor, S., Haberer, J., & Mimiaga, M. J. (2016). Optimizing Pre-Exposure Antiretroviral Prophylaxis Adherence in Men Who Have Sex with Men: Results of a Pilot Randomized Controlled Trial of “Life-Steps for PrEP.†AIDS and Behavior 2016 21:5, 21(5), 1350–1360. https://doi.org/10.1007/S10461-016-1606-4

Mitchell, K. M., Dimitrov, D., Silhol, R., Geidelberg, L., Moore, M., Liu, A., Beyrer, C., Mayer, K. H., Baral, S., & Boily, M.-C. (2021). The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study. The Lancet HIV, 8(4), e206–e215. https://doi.org/10.1016/S2352-3018(21)00022-9

Molina, J.-M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., Tremblay, C., Rojas-Castro, D., Cua, E., Pasquet, A., Bernaud, C., Pintado, C., Delaugerre, C., Sagaon-Teyssier, L., Mestre, S. Le, Chidiac, C., Pialoux, G., Ponscarme, D., Fonsart, J., … Rabian, C. (2017). Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. The Lancet HIV, 4(9), e402–e410. https://doi.org/10.1016/S2352-3018(17)30089-9

Murchu, E. O., Teljeur, C., Hayes, C., Harrington, P., Moran, P., & Ryan, M. (2021). Cost-Effectiveness Analysis of a National Pre-Exposure Prophylaxis (PrEP) Program in Ireland. Value in Health, 24(7), 948–956. https://doi.org/10.1016/J.JVAL.2021.02.005

Naif, H. M. (2013). Pathogenesis of HIV Infection. Infectious Disease Reports, 5(Suppl 1), 26–30. https://doi.org/10.4081/IDR.2013.S1.E6

Organization, W. H. (2021). Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring (Issue March). https://apps.who.int/iris/bitstream/handle/10665/340190/9789240022232-eng.pdf

Pialoux, G., Delaugerre, C., Cotte, L., Raffi, F., Cua, E., & Molina, J.-M. (2016). Pre-exposure prophylaxis: a useful tool to prevent human immunodeficiency virus infection? Clinical Microbiology and Infection, 22(9), 757–767. https://doi.org/10.1016/J.CMI.2016.08.029

PMK, K. (2020). Menuju Indonesia Bebas AIDS 2030 | Kementerian Koordinator Bidang Pembangunan Manusia dan Kebudayaan. https://www.kemenkopmk.go.id/menuju-indonesia-bebas-aids-2030

Qu, D., Zhong, X., Xiao, G., Dai, J., Liang, H., & Huang, A. (2018). Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study. International Journal of Infectious Diseases, 75, 52–59. https://doi.org/10.1016/J.IJID.2018.08.006

Rodger, A. J., Cambiano, V., Phillips, A. N., Bruun, T., Raben, D., Lundgren, J., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., Beloukas, A., Coll, P., Antinori, A., Nwokolo, N., Rieger, A., Prins, J. M., … Janeiro, N. (2019). Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. The Lancet, 393(10189), 2428–2438. https://doi.org/10.1016/S0140-6736(19)30418-0

S, M., TW, C., & AS, F. (2011). Pathogenic mechanisms of HIV disease. Annual Review of Pathology, 6, 223–248. https://doi.org/10.1146/ANNUREV-PATHOL-011110-130254

Si, M., Su, X., Yan, L., Jiang, Y., Liu, Y., Wei, C., & Yan, H. (2020). Barriers and facilitators in pre-exposure prophylaxis (PrEP) use intention among Chinese homosexual men. Global Health Journal, 4(3), 79–86. https://doi.org/10.1016/J.GLOHJ.2020.08.005

Tang, W., Huan, X., Mahapatra, T., Tang, S., Li, J., Yan, H., Fu, G., Yang, H., Zhao, J., & Detels, R. (2013). Factors Associated with Unprotected Anal Intercourse Among Men Who Have Sex with Men: Results from a Respondent Driven Sampling Survey in Nanjing, China, 2008. AIDS and Behavior 2013 17:4, 17(4), 1415–1422. https://doi.org/10.1007/S10461-013-0413-4

Traeger, M. W., Schroeder, S. E., Wright, E. J., Hellard, M. E., Cornelisse, V. J., Doyle, J. S., & Stoové, M. A. (2018). Effects of Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection on Sexual Risk Behavior in Men Who Have Sex With Men: A Systematic Review and Meta-analysis. Clinical Infectious Diseases, 67(5), 676–686. https://doi.org/10.1093/CID/CIY182

UNAIDS. (2017). Blind Spot: Reaching out to men and boys - Addressing a blind spot in the response to HIV. 76. https://www.unaids.org/sites/default/files/media_asset/blind_spot_en.pdf

UNAIDS. (2018). Global AIDS Update 2018 Miles To Go: Closing Gaps Breaking Barriers Righting Injustices. Unaids, pg 6, http://www.unaids.org/sites/default/files/media_as. https://www.unaids.org/sites/default/files/media_asset/miles-to-go_en.pdf

Werner, R. N., Gaskins, M., Ahrens, J., Jessen, H., Kutscha, F., Mosdzen, R., Osswald, W., Sander, D., Schellberg, S., Schwabe, K., Wünsche, T., Dressler, C., Sammons, M., & Nast, A. (2018). Knowledge and use of HIV pre-exposure prophylaxis among men who have sex with men in Berlin – A multicentre, cross-sectional survey. PLoS ONE, 13(9). https://doi.org/10.1371/JOURNAL.PONE.0204067

WHO. (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 2nd edition. Geneva: WHO; 2016. http://apps.who.int/iris/bitstream/handle/10665/85321/9789241505727_eng.pdf?sequence=1

WHO. (2019). WHO | WHO implementation tool for pre-exposure prophylaxis of HIV infection. Who, July. https://apps.who.int/iris/bitstream/handle/10665/279834/WHO-CDS-HIV-18.10-eng.pdf?ua=1

WHO. (2020). Global HIV Programme. World Health Organization. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/prevention/pre-exposure-prophylaxis

Wilandika, A. (2018). Penggunaan Highly Active Antiretroviral Theraphy (HAART) Terhadap Health Related Quality of Life (HRQOL) pada Orang Dengan HIV/AIDS. JURNAL PENDIDIKAN KEPERAWATAN INDONESIA, 4(2), 172–179. https://doi.org/10.17509/JPKI.V4I2.14093

Wong, N. S., Kwan, T. H., Tsang, O. T. Y., Lee, M. P., Yam, W. C., Lam, W., Leung, W. S., Chan, J. M. C., Ho, K. M., & Lee, S. S. (2018). Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted? Scientific Reports 2018 8:1, 8(1), 1–9. https://doi.org/10.1038/s41598-018-30101-9

World Health Organization. (2012). GUIDANCE ON PRE-EXPOSURE ORAL PROPHYLAXIS (PrEP) FOR SERODISCORDANT COUPLES, MEN AND TRANSGENDER WOMEN WHO HAVE SEX WITH MEN AT HIGH RISK OF HIV July 2012. Leonardo, July, 106–106.

World Health Organization. (2019). What’s the 2+1+1? Event-Driven Oral Pre-Exposure Prophylaxis To Prevent Hiv for Men Who Have Sex With Men: Update To Who’s Recommendation on Oral PrEP. World Health Organization, July, 24. http://apps.

World Health Organization Regional Office for South-East Asia. (2010). HIV/AIDS Among Men Who Have Sex With Men And Transgender Populations In South-East Asia : The Current Situation and National Responses. In Journal of Applied Mathematics and Mechanics.

Yusnita, Vera, Hardisman, & Abdiana. (2019). ANALISIS PERILAKU SEKSUAL BERESIKO DAN KEJADIAN HIV PADA LSL. Garuda - Garba Rujukan Digital, 10(3). https://garuda.ristekbrin.go.id/documents/detail/1111738

Zhu, Y., Liu, J., Qu, B., Hu, B., & Zhang, Y. (2016). Relationship between quality of life and unprotected anal intercourse among Chinese men who have sex with men: a cross-sectional study. BMC Public Health 2016 16:1, 16(1), 1–6. https://doi.org/10.1186/S12889-016-3076-Z

Downloads

Published

2023-12-20

How to Cite

Tjahyanto, T., Kusuma, N. C. P., Marcella, A., Ariella, G., & Sarijuwita, A. (2023). PROFILAKSIS PRA-PAJANAN (PPrP) HIV/AIDS PADA LELAKI SEKS LELAKI. PREPOTIF : JURNAL KESEHATAN MASYARAKAT, 6(1), 341–354. https://doi.org/10.31004/prepotif.v6i1.2816

Issue

Vol. 6 No. 1 (2022): April 2022

Section

Articles

License

Copyright (c) 2022 Teddy Tjahyanto, Natasha Cita Paradhita Kusuma, Agnes Marcella, Gladys Ariella, Alicia Sarijuwita

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).